The t(14;20) is a poor prognostic factor in myeloma but is associated with long-term stable disease in monoclonal gammopathies of undetermined significance
about
Many multiple myelomas: making more of the molecular mayhemMolecular pathogenesis of multiple myeloma: basic and clinical updatesFibroblast activation protein α in tumor microenvironment: recent progression and implications (review)Advances in understanding prognosis in myeloma.Impact of high-risk classification by FISH: an eastern cooperative oncology group (ECOG) study E4A03.In multiple myeloma, 14q32 translocations are nonrandom chromosomal fusions driving high expression levels of the respective partner genes.Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival.Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapiesA novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial.APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myelomaProteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markersThe genetic architecture of multiple myeloma.Clinical impact of chromosomal aberrations in multiple myeloma.Understanding the molecular biology of myeloma and its therapeutic implications.Biologic frontiers in multiple myeloma: from biomarker identification to clinical practice.Association of Chromosomal Translocation and MiRNA Expression with The Pathogenesis of Multiple Myeloma.Genetics in myeloma: genetic technologies and their application to screening approaches in myeloma.Cytogenetic Alterations in Multiple Myeloma: Prognostic Significance and the Choice of Frontline Therapy.Risk Stratification in Multiple Myeloma.Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients.The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma.Characterization of a new human plasma cell leukemia cell line UHKT-944.Genomic Aberrations in Multiple Myeloma.Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable?The RAG Model: A New Paradigm for Genetic Risk Stratification in Multiple MyelomaCirculating N-cadherin levels are a negative prognostic indicator in patients with multiple myeloma.Evolutionary biology of high-risk multiple myeloma.Multiple myeloma
P2860
Q26852892-ABABC662-0E77-46BC-9018-80AA28FAC968Q27026205-63A649AA-AD56-4306-86D8-106BF22948A8Q28082504-32D168BB-D649-482E-BAC7-2F0D7494BC9BQ30244061-97ADA0F4-8D9D-4BDA-B101-DFDA4CF9A8C8Q30424188-3C9DD839-E501-48AD-9A5A-49C856DB2281Q33590961-17E946BD-0CF5-4AD0-9222-292CCB9152B0Q34223730-62682A1E-B0A6-47E2-949B-F3C5A798F1D9Q34272540-C98F7C8C-5772-4CB9-8B9D-27CD15ECE2F7Q35984702-D5042956-51C5-4FCC-8E59-1A6063C6AAAAQ36055752-5A9B2608-52B6-4AD0-B1DB-244C9EFE1214Q36665156-8A5EED2B-0AA8-4D63-BB93-297FA59C6B1DQ37718836-640E6431-82D3-4076-A635-CF3EF1F8293DQ37821077-8434C417-1B28-4C34-A097-45E2CC720921Q38065305-74417889-61BB-4F41-9009-54F8356B6EBCQ38165722-2D52FB99-BF15-43D0-8092-E6629482FAB4Q38190971-DDBFAC50-74A6-4007-8EC2-4CA9427EF272Q38348173-5E08D183-29D3-4D00-95E1-462DAC59F21FQ38617375-92498382-6786-4A4A-9959-0426D890016AQ38736249-BE5385F2-A243-4E79-8E50-4A1CA9AB5D45Q38742055-40C3E206-4E7D-4738-9542-23DDD2FD11FBQ38760679-877A95DF-173D-4821-A4C5-11CCBB7E9F8CQ38918719-65B5F2CD-B8F0-4383-B265-B5E9EF0034B6Q38970573-78C2ADE3-799E-4A2A-BADE-732A62B2B303Q39788992-A5808A8B-7570-4471-A142-598A3C6DDC16Q42055422-2E9093F2-2D3A-4805-8C00-E72930A8C617Q46263392-06C85879-2E26-46E6-BCFB-D7A1B2389427Q47913337-B0E147BF-96FE-4517-862C-015EC27A4119Q56657250-17E3C9F3-BDD4-41D9-B65F-FEDFCD8F776E
P2860
The t(14;20) is a poor prognostic factor in myeloma but is associated with long-term stable disease in monoclonal gammopathies of undetermined significance
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The t(14;20) is a poor prognos ...... s of undetermined significance
@ast
The t(14;20) is a poor prognos ...... s of undetermined significance
@en
type
label
The t(14;20) is a poor prognos ...... s of undetermined significance
@ast
The t(14;20) is a poor prognos ...... s of undetermined significance
@en
prefLabel
The t(14;20) is a poor prognos ...... s of undetermined significance
@ast
The t(14;20) is a poor prognos ...... s of undetermined significance
@en
P2093
P2860
P50
P1433
P1476
The t(14;20) is a poor prognos ...... s of undetermined significance
@en
P2093
Alex J Szubert
David M Stockley
Fiona M Ross
Laura Chiecchio
Mark T Drayson
Rebecca K M Protheroe
UK Myeloma Forum
P2860
P304
P356
10.3324/HAEMATOL.2009.016329
P577
2010-04-21T00:00:00Z